Efficacy and safety of patent haemostasis-guided strategies for preventing radial artery occlusion following transradial coronary procedures: a protocol for a systematic review, network meta-analysis, and exploratory component network meta-analysis

BMJ Open. 2026 Sep 17;16(9):e125309. doi: 10.1136/bmjopen-2026-125309.ABSTRACTINTRODUCTION: Patent hemostasis (PH) is important for preventing radial artery occlusion after transradial coronary procedures, but the relative efficacy and safety of different PH-guided strategies remain uncertain. This

X Xiaoping Guo

Intensification of blood pressure lowering therapeutics based on diuretics versus usual management for uncontrolled hypertension in patients with moderate to severe chronic kidney disease (THINK): protocol for an open label, two-parallel group, cluster randomised controlled, superiority, phase 3 trial

BMJ Open. 2026 Sep 17;16(9):e122192. doi: 10.1136/bmjopen-2026-122192.ABSTRACTINTRODUCTION: Hypertension is the primary modifiable risk factor for cardiorenal complications of chronic kidney disease (CKD). It is well established that lowering blood pressure (BP) in patients with CKD reduces renal an

F Floriane Le Vilain-Abraham

Exercise-based cardiac rehabilitation for coronary heart disease

Cochrane Database Syst Rev. 2026 Sep 18;9:CD001800. doi: 10.1002/14651858.CD001800.pub5.ABSTRACTRATIONALE: Coronary heart disease (CHD) is the leading cause of death globally. CHD mortality rates remain steady in low- and middle-income countries but are declining in high-income countries, meaning mo

G Grace Dibben